期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Pharmacists’perceptions of generic drugs in China 被引量:1
1
作者 Yuyao Nie He Wang +2 位作者 linguang zhou Luwen Shi Bin Jiang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2020年第5期364-368,共5页
Perceptions of Chinese pharmacists towards generic drugs were evaluated by a cross-sectional study from Aug.2018 to Dec.2018.Online survey tool Sojump was adopted to release the questionnaires using convenience sampli... Perceptions of Chinese pharmacists towards generic drugs were evaluated by a cross-sectional study from Aug.2018 to Dec.2018.Online survey tool Sojump was adopted to release the questionnaires using convenience sampling.A total of 577 questionnaires by pharmacists were analyzed.A meaningful proportion of pharmacists expressed negative perceptions of generic drugs,such as perceiving generics as less effective,less safe and more likely to cause side effects compared to their branded equivalents.Educational campaigns that focus on misperceptions of generic drugs may be necessary. 展开更多
关键词 Generic drug Generic substitution PERCEPTION PHARMACIST
原文传递
Stakeholder analysis of clinical trials in China: a structural equation model
2
作者 Xiaoyuan Zheng linguang zhou +2 位作者 Bo Gao Song Yang Bin Jiang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2015年第8期552-556,共5页
Stakeholder analysis was conducted to define stakeholders and their role in clinical trials; a conceptual model and hypotheses regarding the relationship of each stakeholder were then constructed based on pharmaceutic... Stakeholder analysis was conducted to define stakeholders and their role in clinical trials; a conceptual model and hypotheses regarding the relationship of each stakeholder were then constructed based on pharmaceutical regulations in China and interviews with experts; Amos 17.0 was utilized to test the model and path analysis. We found that government and hospital are the most powerful stakeholders, while the public and sponsor have little impact on clinical trials. Further measures should be taken by sponsors to promote the development of clinical trials, and the public should be more involved in clinical research. 展开更多
关键词 Clinical trial Stakeholder analysis Structural equation model
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部